Clinical Trial Update: Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on a novel nicotine replacement therapy for tobacco dependence, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence

Drugs mentioned

• Novel Nicotine Replacement Therapy

Snippet

Sponsor: McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. | Conditions: Tobacco Dependence | Phase 3 | Status: COMPLETED | Results posted: 2019-01-08